Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

Also called NCT01788150

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 159 participants (enrolled count) (from the registry)
Sponsor
Svelte Medical Systems, Inc. (from the registry)
Registry
  • NCT NCT01788150
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, Czechia, France, Germany, Netherlands, Sweden, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01788150. Randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2014-05 (actual). Results posted on 2021-05-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
Acronym
DIRECT II
Intervention (Device)
Coronary Stenting
Lead sponsor
Svelte Medical Systems, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01788150
Content hash
edafc011fb8360ab01f1db15d4979a2495bd223c4ab509e25c32bfd1c5ad71ac